Advertisement

Topics

Latest "ARTMS Products Inc." News Stories

12:42 EST 21st February 2019 | BioPortfolio

Here are the most relevant search results for "ARTMS Products Inc." found in our extensive news archives from over 250 global news sources.

More Information about ARTMS Products Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about ARTMS Products Inc. for you to read. Along with our medical data and news we also list ARTMS Products Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of ARTMS Products Inc. Companies for you to search.

Showing "ARTMS Products" News Articles 1–25 of 15,000+

Thursday 21st February 2019

Catalyst Pharmaceuticals defends $375,000 drug price after Bernie Sanders rebuke

Catalyst Pharmaceuticals Inc, rebuked by U.S. Senator Bernie Sanders for its high drug prices, on Thursday defended its $375,000 treatment for a rare disease, saying the price was in line with similar products in the industry.


Nihon Kohden Appoints New CEO of North American Operations

New CEO Joins Newly Selected Executive Officers to Optimize US Organization Nihon Kohden, a U.S. market leader in precision medical products and services, today announced the appointment of Yasuhiro Yoshitake as its new president and CEO. Yoshitake is taking over the helm of the organization from Dr. Wilson P. Constantine, who led the organization ...

Equipment Safely Treats Microbiological Cultures

Product AnnouncementThe ECO LCD controller from BMT allows for up to nine programs along with USB and Ethernet communication. Contr


Alzheimer’s Treatment May Lie in “Holy Herb”

In 2015, Youyou Tu won the Nobel Prize in Physiology or Medicine for her work and discovery of artemisinin—a compound derived from the sweet wormwood plant—as a treatment for malaria. Tu’s work underscored not only the immense value of natural products in fighting disease but also the importance of evaluating traditional folk remedies during the […] The post Alzheimer’s Treatment May...

International Hemp Oil Company, Functional Remedies, Acquires New Lab, Increasing Production Capacity Ten-Fold

Premier Hemp Oil Producer Expands into New 25,000-Square-Foot Lab and 4,000-Square-Foot Executive Offices Functional Remedies, the only vertically integrated manufacturer of whole-plant hemp oil products, announced a major expansion of its lab and production facility from 2,000 square feet to a new 25,000-square-foot facility located in Louisvil...

Catalyst defends $375,000 drug price after Bernie Sanders rebuke

Catalyst Pharmaceuticals Inc, targeted by U.S. Senator Bernie Sanders for its high drug prices, said on Thursday that prices of its treatment for a rare neurological disorder were "in line" with similar products in the industry.

CaniBrands Partners with MediaJel to Launch and Promote a Nationwide E-commerce Platform for CBD Products

New e-commerce solutions will simplify shopping for U.S. CBD consumers WALNUT CREEK, Calif. (PRWEB) February 21, 2019 Toronto, Canada-based cannabis-infused products company CaniBrands™ is partnering with MediaJel™, a world-leading creative and multimedia agency for the mobile era, to launch a leading edge e-commerce platform for CBD products in the U.S. market to help consumers more easily f...

Wedderspoon Unveils First-of-its-Kind Apple Cider Drinking Vinegars and Concentrates

U.S. Leader in Genuine Manuka Honey Launches First Apple Cider Drinking Vinegar Infused with Manuka Honey and Apple Cider Vinegar Concentrates at Natural Products Expo West Wedderspoon, the #1 selling Manuka Honey brand in the U.S., today announced the launch of its newest product lines, Apple Cider Drinking Vinegars and Apple Cider Vi...

STAT Plus: Pharmalittle: Pfizer suffers a setback with a best-selling pill; J&J is subpoenaed over baby powder

J&J received subpoenas from the Department of Justice and the Securities and Exchange Commission related to the safety of its baby powder products.

Bona Vida Announces Launch of Global CBD Platform and Simultaneous Close of Financing Round

Bona Vida, Inc. www.bonavida.com (“Bona Vida” or the “Company”) is excited to announce the launch of its global CBD platform, focused on developing a portfolio of brand and product verticals within the animal and adult health and wellness space. The Company will be exclusively focused on CBD derived from industrial hemp, with the goal of ...

Johnson & Johnson Baby Powder at Issue as U.S. Subpoenas Company

Johnson & Johnson said in a regulatory filing that it had received subpoenas from the Justice Department and the Securities and Exchange Commission amid inquiries into its talc-based products.

Guiding Principles on Ethics in Digital Health Produced During a Seminar at Stanford Libraries

Proteus Digital Health and more than 30 representatives from technology, pharmaceutical, healthcare, public policy, law and bioethics convene at Stanford to address the responsibility around management of personal data. Stanford Libraries and more than 30 partners, including Proteus Digital Health, today unveiled

Stratasys Brings Full-Color Digital Dental Impressions to Life

J720 Dental 3D Printer sets new standard in laboratory 3D Printing, combining accuracy, multi-material and full color functionality – at 1.75x throughput LMT LAB DAY CHICAGO – Injecting new levels of 3D printed realism into the dental industry, the new Stratasys (NASDAQ: SSYS) J720 Dental creates faster turnaround times so dental l...

EU measures in support of generic pharmaceuticals producers

The EU is adopting new rules which should boost the competitiveness of EU producers of generic medicines and biosimilar products... The post EU measures in support of generic pharmaceuticals producers appeared first on

ResMed, Fisher & Paykel Healthcare announce settlement of global patent infringement litigation

The settlement involves no payment or admission of liability by either side. Under the agreement, all ongoing infringement proceedings against named products will be dismissed, and each party The post ResMed, Fisher & Paykel Healthcare announce settlement of global patent infringement litigation appeared first on Compelo Medical Devices.

OptiBiotix cholesterol product 'generally recognised as safe' by US independent expert panel

OptiBiotix Health plc (LON:OPTI) said its cholesterol product had been generally recognised as safe (GRAS) by an independent expert panel in the US. OptiBiotix Chief Executive Stephen O’Hara tells Proactive London why the company, which is developing products to tackle obesity, cardiovascular disease and diabetes, said sign-off for its Lactobacillus plantarum LPLDL probiotic strain represented...

Spectrum Pharmaceuticals Announces Fourth Quarter and Full Year 2018 Financial Results Conference Call

Spectrum Pharmaceuticals (NasdaqGS: SPPI), announced today it will host a conference call with management to discuss the fourth quarter and full year 2018 financial results, provide an update on the company's business, and discuss expectations for the future on Thursday, February 28, 2019 at 4:30 p.m. Eastern/1:30 p.m. Pacific. Conference Call ...

Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care published form 20-F for the fiscal year 2018

DGAP-News: Fresenius Medical Care AG & Co. KGaA / Key word(s): Miscellaneous 21.02.2019 / 11:51 The issuer is solely responsible for the content of this announcement. February 21, 2019 Fresenius Medical Care published form 20-F for the fiscal year 2018 Fresenius Medical Care, the world's largest provider of dialysis products and services, announced that it has filed the annual report ...

Co-Diagnostics, Inc. Announces Mosquito Vector Control Training Course in the Dominican Republic

Trainings will be conducted for staff and customers of Laboratorios Franja, including demonstrations of Company’s vector control products Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that their distributor in the Dominica...

AAT and DMG MORI USA join hands for on-machine measurement software

Applied Automation Technologies, Inc. and DMG MORI USA Inc. will offer this innovative technology as a solution within the DMG MORI Qualified Products program.

Innovus Pharma Announces Regulatory Filings by its International Distribution Partner, Lavasta Pharma, for ProstaGorx® in Certain Gulf Countries

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the “Company”) (OTCQB Venture Market: INNV), an emerging over-the-counter (“OTC”) consumer goods and specialty pharmaceutical company engaged in the commercialization, licensing and development of safe and effective non-prescription medicine and consumer care products to improve men’s a...

Catalyst defends drug price after Bernie Sanders' rebuke

Catalyst Pharmaceuticals Inc, targeted by U.S. Senator Bernie Sanders for high drug prices, said on Thursday that prices of its treatment for a rare neurological disorder were "in line" with similar products in the industry.

HuaSin In-licenses China Rights to HPV Diagnostic from Spain's Genomica

HuaSin Science of Guangzhou obtained exclusive China rights to a test that offers early detection of HPV, a precursor to cervical cancer, from Genomica of Madrid. HuaSin, which will produce the test under its own DiBao label, has started the China registration process and expects a China launch in 2021. HuaSin distributes clinical laboratory instruments, medical devices and reagents, manufactures ...

Global Scratch Resistant Polypropylene Compound For Automotive Interior Market Research Report 20122024 [Report Updated: 01011970] Prices from USD $1800

The global Scratch Resistant Polypropylene Compound For Automotive Interior market will reach Volume Million USD in 2017 with CAGR xx% 20192023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.Based...

Dermapharm continues to drive development of new products

DGAP-News: Dermapharm Holding SE / Key word(s): Product Launch 21.02.2019 / 07:30 The issuer is solely responsible for the content of this announcement. Dermapharm continues to drive development of new products New products for the treatment of acute hay fever symptoms open up significant market potential bite away(R) successful in all distribution channels and receives award as on...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks